Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Industry IG Compliance Group Supports FDA Systems Model For Audits

Executive Summary

The "Ad Hoc OIG Compliance Group" will advocate the "systems-based" auditing approach recommended by FDA when it meets with the HHS Inspector General to discuss a pharmaceutical industry compliance policy guidance.

You may also be interested in...



PhRMA Marketing Rule Codification Could Re-Emerge On Capitol Hill

Legislation to codify PhRMA's voluntary marketing guidelines would have a strong chance of passing in 2003, Arnold & Porter Partner John Bentivoglio told the Health Industry Group Purchasing Association annual meeting Feb. 3 in Half Moon Bay, Calif

PhRMA Marketing Rule Codification Could Re-Emerge On Capitol Hill

Legislation to codify PhRMA's voluntary marketing guidelines would have a strong chance of passing in 2003, Arnold & Porter Partner John Bentivoglio told the Health Industry Group Purchasing Association annual meeting Feb. 3 in Half Moon Bay, Calif

Market Share-Based Rebates Are Not Rx Switch Deals, Manufacturers Argue

Drug rebates based on market share and payments to PBMs to disseminate product information are not switching arrangements, a group of 19 manufacturers maintain in comments on the HHS Inspector General's draft compliance guidance

Related Content

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel